Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KDSR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DUSP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGF13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEIS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AHSA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLEKHA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CECR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GART - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FERMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPAST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLXNC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on